Arthneeti

Kovai Medical Center & Hospital Share Price & Earnings Call Analysis

₹5,887.50+0.24% today
Market cap
₹6,441 Cr
P/E
25.13
ROE
20.46%
PEG
0.90
Price to sales
3.92
Debt to equity
0.31
52W high / low
₹6,292 / ₹2,387
Sales growth (5Y)
18.09%
EBITDA margin
27.85%
Net profit margin
15.52%
Promoter holding
56.54%
Sales (last year)
₹1,644 Cr

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Aster DM Quality Care LtdGood growth
    3
See all potential multibaggersWhere does Kovai Medical rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹921 Cr—
240%+Flat₹575 Cr21.9
3Aster DM Quality Care Ltd20–40%Up 2%+₹59,405 Cr164.6
420–40%Up 2%+₹551 Cr18.5
520–40%Up 0–2%₹1,635 Cr16.5
620–40%Flat₹1.21L Cr57.7

Sign up free to see every company in the sector ranking and track Kovai Medical.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of Kovai Medical

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Kovai Medical

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +267275303321321315344355357374392407414
Expenses +200206217225229229248252256268285291303
Operating Profit67688596928696103101106107116111
OPM %25%25%28%30%29%27%28%29%28%28%27%28%27%
Other Income +5645655666678
Interest101087778999986
Depreciation22222323242424252526272829
Profit before tax41425871676167757476788784
Tax %25%26%26%25%22%25%25%23%26%25%24%25%25%
Net Profit +31314353524651585557596563
EPS in Rs27.9328.3839.6748.5347.6941.8146.3252.8249.9952.3053.7959.4257.89

Financials of Kovai Medical

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +4024655315886287126909051,0201,2201,3711,586
Expenses +3073744064594945404956457468749811,147
Operating Profit9492125129135171195261274346390439
OPM %23%20%23%22%21%24%28%29%27%28%28%28%
Other Income +7867810121214212128
Interest201715131518334643373632
Depreciation2121243436526885899298109
Profit before tax5962928993112106141155238278326
Tax %35%35%35%35%35%15%27%26%25%24%25%25%
Net Profit +39406058609578104116180209244
EPS in Rs35.3736.9554.8152.9954.9686.4471.0095.28105.80164.25190.96223.41
Dividend Payout %4%7%5%6%5%3%4%6%9%6%5%7%

Financials of Kovai Medical

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital111111111111111111111111
Reserves1271652242763324204995987088781,0751,308
Borrowings +163158125202378543623550511310415403
Other Liabilities +8596103116129134148184209240299344
Total Liabilities3864304646058501,1081,2811,3431,4391,4391,8012,066
Fixed Assets +2813373544434696431,0331,0851,0881,1181,2831,474
CWIP17106132273004552339154135
Investments444000000001
Other Assets +8578100149153165203253328282364457
Total Assets3864304646058501,1081,2811,3431,4391,4391,8012,066

Financials of Kovai Medical

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +97859987126166186262263344353362
Cash from Investing Activity +-80-113-83-192-352-349-180-292-358-290-612-230
Cash from Financing Activity +-43-24-506016011338-119-86-24362-58
Net Cash Flow-26-53-33-45-66-7044-149-180-189-19773
Free Cash Flow601463-41-151-10251631362061111
CFO/OP119%109%99%92%117%115%106%115%110%116%106%102%

Financials of Kovai Medical

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days978864788589
Inventory Days252220232023191918171616
Days Payable534737434746292035302920
Cash Conversion Cycle-19-19-9-12-21-19-26-9-7-55
Working Capital Days-60-56-50-48-55-39-56-49-48-49-57-58
ROCE %27%25%31%24%18%15%13%16%17%23%23%22%
59out of 100

Momentum score · price trend

59 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−8.2%50%
Last 6 months+4.6%62%
Last 3 months+0.7%69%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Kovai Medical: 0.4 × 50 + 0.4 × 62 + 0.2 × 69 = 59.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre (Q2 FY27)

    Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves

  • Shalby (Q2 FY27)

    Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S

  • Metropolis Healt (Q2 FY27)

    Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre

  • Nephrocare Health Services (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services

Compare:vs Apollo Hospitalsvs Max Healthcarevs Manipal Health